In this study, we found that RECQL4 expression was aberrantly elevated in both clinical LUAD tissues and tumor cell lines, and higher levels of RECQL4 expression were associated with poor prognosis and worse clinicopathological characteristics in LUAD patients. The gene discussed is RECQL4; the disease is neoplasm.